Evidence map›Paper›PMID 24410909›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2014

Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts.

A Gaughan, J Wang, R P Pelletier, T Nadasdy, S Brodsky, S Roy, M Lodder, D Bobek, S Mofatt-Bruce, R L Fairchild and 2 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. T Cells With ActivatedFrontiers in immunology · 2022
    Article
  7. Article
  8. Article
  9. Phenotypic Characterization of Circulating CD4Journal of immunology research · 2018
    Article
  10. Article
  11. Article
  12. Frontiers in immunology · 2017
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

A GaughanDepartment of Surgery, Ohio State University Wexner Medical Center, Columbus, OH.
J Wang
R P Pelletier
T Nadasdy
S Brodsky
S Roy
M Lodder
D Bobek
S Mofatt-Bruce
R L Fairchild
M L Henry
G A Hadley
The Ohio State University Wexner Medical Center · USCleveland Clinic · US

Funding

The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
Surgery CoreP01AI087586 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI VALUJSKIKH, ANNA · 2010 to 2019
$17.2M
The Ohio State University Center for Clinical and Translational Science (UL1)UL1TR000090 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$7.9M
KIDNEY RESTRICTED CTL AND ALLOGRAFT REJECTIONR01AI036532 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HADLEY, GREGG A · 2000 to 2010
$3.1M
Kidney-restricted CTL and Allograft RejectionR56AI036532 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HADLEY, GREGG A · 2005 to 2005
$297k
KIDNEY RESTRICTED CTL AND ALLOGRAFT REJECTIONR29AI036532 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HADLEY, GREGG A · 1994 to 1998
–
KIDNEY RESTRICTED CTL AND ALLOGRAFT REJECTIONR21AI036532 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HADLEY, GREGG A · 1999 to 1999
–
NCATS NIH HHS UL1 TR000090NCATS NIH HHS UL1 TR001070NIAID NIH HHS AI036532NIAID NIH HHS P01 AI087586NIAID NIH HHS R01 AI036532NIAID NIH HHS R21 AI036532NIAID NIH HHS R56 AI036532
6 · The paper itself

Abstract

We utilized mouse models to elucidate the immunologic mechanisms of functional graft loss during mixed antibody-mediated rejection of renal allografts (mixed AMR), in which humoral and cellular responses to the graft occur concomitantly. Although the majority of T cells in the graft at the time of rejection were CD8 T cells with only a minor population of CD4 T cells, depletion of CD4 but not CD8 cells prevented acute graft loss during mixed AMR. CD4 depletion eliminated antidonor alloantibodies and conferred protection from destruction of renal allografts. ELISPOT revealed that CD4 T effectors responded to donor alloantigens by both the direct and indirect pathways of allorecognition. In transfer studies, CD4 T effectors primed to donor alloantigens were highly effective at promoting acute graft dysfunction, and exhibited the attributes of effector T cells. Laser capture microdissection and confirmatory immunostaining studies revealed that CD4 T cells infiltrating the graft produced effector molecules with graft destructive potential. Bioluminescent imaging confirmed that CD4 T effectors traffic to the graft site in immune replete hosts. These data document that host CD4 T cells can promote acute dysfunction of renal allografts by directly mediating graft injury in addition to facilitating antidonor alloantibody responses.

Indexed as

AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFlow CytometryGraft RejectionIsoantibodiesIsoantigensKidney DiseasesKidney TransplantationLaser Capture MicrodissectionLymphocyte DepletionMiceMice, Inbred BALB CMice, Inbred C57BLMice, Inbred DBAMice, KnockoutIsoantibodiesIsoantigensAdoptive transferantibody-mediated rejectionELISPOTgraft infiltrating lymphocytesT cell-mediated rejection

Identifiers

PMID24410909
PMCPMC4128005
OpenAlexW2156005708

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.